Double - blind randomized evaluation of <font color="red">intercostal_2</font> <font color="red">nerve_2</font> <font color="red">blocks_2</font> as an adjuvant to <font color="red">subarachnoid_2</font> <font color="red">administered_2</font> <font color="red">morphine_2</font> for post - thoracotomy analgesia . 
<br>
<br> BACKGROUND AND OBJECTIVES Thoracotomy is associated with pain and compromised pulmonary function . <font color="red">Intercostal_2</font> <font color="red">nerve_2</font> <font color="red">blocks_2</font> <font color="red">(_2</font> <font color="red">INB_2</font> <font color="red">)_2</font> and <font color="red">subarachnoid_2</font> <font color="red">morphine_2</font> <font color="red">(_2</font> <font color="red">SM_2</font> <font color="red">)_2</font> act on different portions of the pain pathway . Each is effective for post - thoracotomy pain relief . The combination of these two modalities in relieving post - thoracotomy pain and improving postoperative pulmonary function has not been investigated . 
<br> METHODS In a double - blind study , 20 patients undergoing lateral thoracotomy for lung resection were randomized to receive 0.5 mg <font color="red">SM_2</font> <font color="red">preoperatively_1</font> <font color="red">and_1</font> <font color="red">INB_2</font> <font color="red">with_1</font> <font color="red">bupivacaine_2</font> <font color="red">(_1</font> <font color="red">INB+_1</font> <font color="red">)_1</font> prior to wound closure or 0.5 mg <font color="red">SM_2</font> <font color="red">with_1</font> <font color="red">INB_2</font> <font color="red">using_1</font> <font color="red">saline_2</font> <font color="red">(_1</font> <font color="red">INB-_1</font> <font color="red">)_1</font> <font color="red">._1</font> Visual analog scale pain scores at rest , with cough , and with movement of the ipsilateral arm , forced expiratory volume in 1 second ( FEV1 ) , and forced vital capacity ( FVC ) were measured at 4 , 24 , 48 , and 72 hours after the operation . Opioid use was measured during the initial 24 hours after the operation . 
<br> RESULTS At 4 hours , the <font color="red">INB+_1</font> group demonstrated better FEV1 ( 56.6% vs. 40.4% of baseline , P < .05 ) and FVC values ( 54.6% vs. 39.6% of baseline , P < .05 ) and less resting and cough pain ( P < .05 ) . However , FEV1 continued to decline in the <font color="red">INB+_1</font> group at 24 hours to lower than the <font color="red">INB-_1</font> group although pain scores were similar beyond 4 hours . Opioid usage during the first 24 hours was similar ( <font color="red">INB-_1</font> <font color="red">,_1</font> 16.7 mg vs. <font color="red">INB+_1</font> <font color="red">,_1</font> 13.2 mg , P = .7 ) . 
<br> CONCLUSIONS Although postoperative <font color="red">INB_2</font> provided modest improvements in pain and pulmonary function when used as an adjuvant to 0.5 mg <font color="red">SM_1</font> for post - thoracotomy analgesia , the benefits were transient . The authors do not recommend adding <font color="red">INB_2</font> for patients undergoing lateral thoracotomy who receive 0.5 mg <font color="red">SM_1</font> <font color="red">._1</font>